A study recently published in the journal Alzheimer’s & Dementia examined the relationship between certain cardiovascular disease medications and the risk for dementia. The study analyzed data ...

Researchers are uncovering connections between cardiovascular health and cognitive decline, revealing how certain medications designed to protect the heart may also reduce dementia risk.

Share on Pinterest Which cardiovascular drugs may help prevent, and which may increase the risk of dementia? Image credit: VICTOR TORRES/Stocksy. Dementia prevention is a critical area of research ...

A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered by Canada's public pharmacare programs for two common cardiovascular ...

In this review we consider the effects of orlistat on cardiovascular disease (CVD) risk factors. Furthermore, we present the effects of the combination of orlistat with hypolipidemic drugs ...

Algorae Pharmaceuticals’ new AI-168 drug combination that partly involves cannabidiol has shown early potential to improve on existing treatments to protect the heart from cardiovascular stressors.

Consideration of Two Important Cardiovascular Clinical Contexts" compared all provincial drug formulary reimbursement criteria for medications recommended to treat heart failure with a reduced ...

which is reflected in the 42% increase in cardiac therapy drug sales over two years. Data from Pharmarack shows the moving annual total (MAT) for cardiac drug sales in the state increased from Rs ...

Age is well recognized as a powerful prognostic factor in the setting of cardiovascular disease ... efficacy and dosing of many medications. Decreases in lean muscle mass affect the volume ...

Lp(a) HORIZON aims to show superiority for the antisense drug over placebo in reducing major cardiovascular events (MACE) in patients with established cardiovascular disease and elevated levels of ...